Basimglurant
≥99%
- Product Code: 99737
CAS:
802906-73-6
| Molecular Weight: | 325.77 g./mol | Molecular Formula: | C₁₈H₁₃ClFN₃ |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2-8℃ |
Product Description:
Basimglurant is primarily investigated for its potential therapeutic applications in the field of neuroscience. It acts as a negative allosteric modulator of the metabotropic glutamate receptor 5 (mGluR5), which plays a significant role in regulating synaptic plasticity and neuronal communication. This mechanism makes it a promising candidate for treating central nervous system disorders, particularly major depressive disorder (MDD). Clinical studies have explored its efficacy in alleviating depressive symptoms, with a focus on its ability to modulate glutamate signaling, which is often dysregulated in depression. Additionally, basimglurant has been studied for its potential in addressing anxiety and other mood-related conditions. Its unique action on mGluR5 receptors offers a novel approach compared to traditional antidepressants, potentially providing benefits with fewer side effects. Research is ongoing to further evaluate its safety, efficacy, and broader applications in mental health disorders.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.005 | 10-20 days | ฿35,910.00 |
+
-
|
| 0.010 | 10-20 days | ฿51,300.00 |
+
-
|
Basimglurant
Basimglurant is primarily investigated for its potential therapeutic applications in the field of neuroscience. It acts as a negative allosteric modulator of the metabotropic glutamate receptor 5 (mGluR5), which plays a significant role in regulating synaptic plasticity and neuronal communication. This mechanism makes it a promising candidate for treating central nervous system disorders, particularly major depressive disorder (MDD). Clinical studies have explored its efficacy in alleviating depressive symptoms, with a focus on its ability to modulate glutamate signaling, which is often dysregulated in depression. Additionally, basimglurant has been studied for its potential in addressing anxiety and other mood-related conditions. Its unique action on mGluR5 receptors offers a novel approach compared to traditional antidepressants, potentially providing benefits with fewer side effects. Research is ongoing to further evaluate its safety, efficacy, and broader applications in mental health disorders.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :